Biological and clinical validation of atypical depression

Psychiatry Research

Volumn 60, Issue 2-3, 1996, Pages 191-198

  McGinn, Lata K ^a   Asnis, Gregory M ^a   Rubinson, Eileen ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Affective disorder; Cortisol; Desipramine; Norepinephrine; Sex ratio

Indexed keywords

DESIPRAMINE; HYDROCORTISONE; NORADRENALIN;

ADULT; AGE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; FEMALE; HORMONE RELEASE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MOOD; PRIORITY JOURNAL; SEX;

EID: 0029996339     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(96)02781-3     Document Type: Article

References (26)

1. American Psychiatric Association. (1994) DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th edn. American Psychiatric Press, Washington, DC.
2. Asnis, G.M., Halbreich, U., Rabinovich, H., Ryan, N.D., Sachar, E.J., Nelson, B., Puig-Antich, J. and Novacenko, H. (1985) The cortisol response to desipramine in endogenous depressives and normal controls: preliminary findings. Psychiatry Res 14, 225-233.
3. Asnis, G.M., Lemus, C.Z. and Halbreich, U. (1986) The desipramine cortisol test - a selective noradrenergic challenge (relationship to other cortisol tests in depressives and normals). Psychopharmacol Bull 22, 571-578.
4. Asnis, G.M., McGinn, L.K. and Sanderson, W.C. (1995) Atypical depression: clinical aspects and noradrenergic function. Am J Psychiatry 152, 31-36.
5. Asnis, G.M., McGinn, L.K. and Sanderson, W.C. (1996) Clinical and biological characteristics of atypical depression. In: Widiger, T.A., Frances, A.J., Pincus, H.A., First, M.B., Ross, R. and Davis, W. (Eds.), DSM-IV Sourcebook. Vol. 2. American Psychiatric Press, Washington, DC.
6. Asnis, G.M., Sanderson, W.C. and van Praag, H.M. (1993) The cortisol response to intramuscular desipramine in patients with major depression and normal control subjects. Psychiatry Res 44, 237-250.
7. Cooper, T.D., Allen, D. and Simpson, G.M. (1975) A sensitive GLC method for the determination of imipramine and desmethyl-imipramine using a nitrogen detector. Psychopharmacology Communications 4, 445-454.
8. Davidson, J.R.T., Miller, R.D., Turnbull, C.D. and Sullivan, J.L. (1982) Atypical depression. Arch Gen Psychiatry 39, 527-534.
9. Derogatis, L.R., Lipman, R.S., Rickels, K., Uhlenhuth, E.H. and Covi, L. (1974) The Hopkins Symptom Checklist (HSCL): a self-report inventory. Behav Sci 19, 1-23.
10. Endicott, J., Cohen, J., Nee, J., Fleiss, J. and Sarantakos, S. (1981) Hamilton Depression Rating Scale: extracted form and change versions of the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 38, 98-108.
11. Laakman, G., Schoen, H.W., Blaschke, D. and Wittman, M. (1985) Dose-dependent growth hormone, prolactin and cortisol stimulation after i.v. administration of desipramine in human subjects. Psychoneuroendocrinology 10, 83-93.
12. Laakman, G.M., Wittman, M., Schoen, H.W., Zygan, K., Weiss, A., Meissner, O.A. and Stalla, G.K. (1986) Effects of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desipramine-induced pituitary hormone stimulation in humans. III: Hypothalamo-pituitary-adrenocortical axis. Psychoneuroendocrinology 11, 475-489.
13. Liebowitz, M.R., Quitkin, F.M., Stewart, J.W., McGrath, P.J., Harrison, W.M., Rabkin, J.G., Tricamo, E., Markowitz, J.S. and Klein, D.S. (1984) Phenelzine versus imipramine in atypical depression. Arch Gen Psychiatry 41, 669-677.
14. Quitkin, F.M., Harrison, W.M., Stewart, J.W., McGrath, P.J., Tricamo, E., Ocepek-Welikson, K., Rabkin, J.G., Wager, S.G., Nunes, E. and Klein, D.F. (1991) Response to phenelzine and imipramine in placebo responders with atypical depression. Arch Gen Psychiatry 48, 319-323.
15. Quitkin, F.M., McGrath, P., Stewart, J.W., Harrison, W., Wager, S.G., Nunes, E., Rabkin, J.G., Tricamo, E., Markowitz, J. and Klein, D.F. (1989) Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Arch Gen Psychiatry 46, 787-793.
16. Quitkin, F.M., Stewart, J.W., McGrath, P.J., Liebowitz, M.R., Harrison, W.M., Tricamo, E., Klein, D.F., Rabkin, J.G., Markowitz, J.S. and Wager, S.G. (1988) Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. Am J Psychiatry 145, 306-311.
17. Rabkin, J.G., Stewart, J.W., Quitkin, F.M., McGrath, P.J., Harrison, W.M. and Klein, D.F. (1996) Should atypical depression be included as a separate entity in DSM-IV? A review of the research evidence. In: Widiger, T.A., Frances, A.J., Pincus, H.A., First, M.B., Ross, R. and Davis, W. (Eds.), DSM-IV Sourcebook. Vol. 2. American Psychiatric Press, Washington, DC.
18. Randrup, A. and Braestrup, P. (1977) Uptake inhibition of bio-genie amines by newer antidepressant drugs: relevance to the dopamine hypothesis. Psychopharmacology 53, 309-319.
19. Ravaris, C.L., Robinson, D.S., Ives, J.O., Nies, A. and Bartlett, D. (1980) Phenelzine and amitriptyline in the treatment of depression: a comparison of past and present studies. Arch Gen Psychiatry 37, 1075-1080.
20. Robinson, D.S., Nies, A., Ravaris, C.L., Ives, J.O. and Lamborn, K.R. (1974) Treatment response to MAO inhibitors: relation to depressive typology and blood platelet MAO inhibitors. In: Stuttgart, A.J. (Ed.), Classification and Prediction of Outcome of Depression. Schattauer Verlag, Berlin, pp. 259-267.
21. Robinson, D.S., Nies, A., Ravaris, C.L. and Lamborn, K.R. (1973) The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive-anxiety states. Arch Gen Psychiatry 29, 407-413.
22. Spitzer, R.L. and Endicott, J. (1975) Schedule for Affective Disorders and Schizophrenia: Lifetime Version. Biometrics Research Division, New York State Psychiatric Institute, New York.
23. Spitzer, R.L., Endicott, J. and Robins, E. (1977) Research Diagnostic Criteria for a Selected Group of Functional Disorders. 4th edn. Biometrics Division, New York State Psychiatric Institute, New York.
24. Spitzer, R.L., Endicott, J. and Robins, E. (1978) Research Diagnostic Criteria. Arch Gen Psychiatry 35, 777-782.
25. West, E.D. and Dally, P.J. (1959) Effects of iproniazid in depressive syndromes. Br Med J 1, 1491-1494.
26. Wilkinson, L. (1990) SYSTAT: The System for Statistics for the PC. SYSTAT, Inc., Evanston, IL.